1 product (1 unit)
Added to cart.

15x points! Online only! Starting January 5, 2026! Earn more points with the Kautoku bonus points calendar. Business customers only.

10.10 USD

Pack size 
1 item
Quantity

 

Add to cart

Add to favorites

Other Products |Fostair Inhaler 200/6mcg 120D

【COL-41b37e457e99b76290416539e06c33530c46886a】
  • Reduced tax rate item
  • Return restrictions apply
CategoryOther Products / General Merchandise / Other Products
10.10 USD

View other quantities, colors and sizes

View other quantities, colors and sizes

Recommended Other Products products

Customers who viewed this item also viewed

Great deals on popular drinks and food!

Product description

Fostair Inhaler 200/6mcg 120D Product DescriptionFostair Inhaler 200/6mcg 120D is a cutting-edge respiratory medication designed for the management of asthma and chronic obstructive pulmonary disease (COPD). This inhaler combines the rapid action of formoterol (a long-acting beta2-agonist, LABA) with the anti-inflammatory properties of beclometasone (a corticosteroid), offering both relief and control for patients with breathing difficulties.Technical Specifications:- Active ingredients: 200 mcg of beclometasone dipropionate and 6 mcg of formoterol fumarate dihydrate per actuation- Dose counter: Yes, providing clear visibility of remaining doses- Delivery mechanism: Pressurized metered-dose inhaler (pMDI)- Number of doses: 120 actuations per inhaler- Storage requirements: Store below 25°C; do not freeze- Shelf life: Check packaging for expiry dateCommon Applications:- Asthma management: Regular treatment for adults whose asthma is not adequately controlled with corticosteroids and 'as needed' short-acting bronchodilators- COPD treatment: Symptomatic treatment for adults with severe COPD and a history of repeated exacerbationsUser Groups:- Adults with asthma or COPD- Patients requiring a combination therapy for improved lung function- Individuals needing a maintenance and reliever therapy in one inhalerSupplier Overview:Chiesi Australia is a subsidiary of the Chiesi Group, an international company with over 85 years of experience in the pharmaceutical sector. Specializing in respiratory, neonatology, rare disease, and special care therapeutics, Chiesi is committed to research and development, aiming to improve the quality of life for patients with innovative and effective treatments. As an authority in the respiratory product category, Chiesi Australia brings expertise and dedication to the healthcare market, ensuring that products like the Fostair Inhaler meet the highest standards of quality, safety, and efficacy. With a strong focus on sustainability and ethical practices, Chiesi Australia is a trusted name for healthcare professionals and patients alike.
Brand:Chiesi AustraliaSKU:PHA19121Tags:mcenter, Pharma, Pharmaceutical, Pharmacy
Other Products |Fostair Inhaler 200/6mcg 120D
Other Products |Fostair Inhaler 200/6mcg 120D

Product reviews

Customer rating